Clinical trial
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00033631
Study timeline
Study start (unknown)2002-03-01Date precision: month
Registry last updated2023-01-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
70.2 Gy 3D-CRT/IMRTRADIATION
79.2 Gy 3D-CRT/IMRTRADIATION
Sponsors & collaborators
Radiation Therapy Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Kansas CityMissouri, United States8PhiladelphiaPennsylvania, United States3MontrealQuebec, Canada2Ann ArborMichigan, United States2RaleighNorth Carolina, United States2BrooklynNew York, United States2Overland ParkKansas, United States2DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1San FranciscoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00033631 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.